Appropriate additions include structured resistance training, intermittent fasting protocols, and optimized protein intake
Clinical Trial Results SURMOUNT-1 trial: Average weight loss of ~20% of total body weight
Alongside lifestyle recommendations, your care plan may include a prescription for weight loss medication
If you dont lose at least 10% of your body weight, you get a full refund
It blends science-based GLP-1 microdosing with lifestyle guidance thats easy to follow, and the fact is that many fitness-minded patients want control, not dramatic changes
(See Figure 2 for a timeline of key activities associated with the GLP-1 coverage demonstrations.) Medicare coverage of GLP-1s for obesity begins in July 2026 through the Medicare GLP-1 Bridge and will be extended through the end of 2027 CMS will provide Part D beneficiaries with coverage of select GLP-1s for obesity from July 1, 2026 to December 31, 2027 (originally December 31, 2026) through the Medicare GLP-1 Bridge, which is a short-term demonstration established using Section 402 demonstration authority